Our Company Vision

“OPTIMUM OUTCOMES”

Imalux® Corporation is the leader in commercializing optical coherence tomography (OCT) systems for site-of-care tissue imaging.

The Company’s Niris® Imaging System provides real-time, high resolution images of tissue structures that are useful in identifying a broad range of diseases and abnormalities, including many types of  cancers. Niris is a valuable tool to aid in the detection and diagnosis of diseases in their earliest stages, precise guidance of biopsy and surgery, and in post-treatment surveillance in a multitude of clinical applications.

Demand for diagnostic and surgical procedures is growing at a rapid rate, driven by an aging population, the availability of minimally invasive techniques, a better understanding of early indicators of disease, developing nations with expanding health care delivery needs, and an increasing public awareness of techniques for screening and treating abnormalities at an early stage of development.

Globally, the healthcare community is searching for ways to streamline and reduce the costs associated with the delivery of care while improving clinical outcomes. “Standard of Care,” “Standard Practices,” “Clinical Pathways” are phrases that have evolved to describe the desire and efforts to improve clinical outcomes in the most efficient and cost-effective manner. One answer to the dilemma is to have patient concerns addressed in “a single episode of care” - the ability of the clinician to “see and treat” in a single patient visit.

To optimize the delivery of health care, from both cost and outcome perspectives, it is increasingly important to diagnose and treat disease with individuality and utmost accuracy… where health services are most frequently delivered … in the office, clinic, ambulatory surgery center, operating room, and other evolving patient settings without increasing infrastructure and staffing. 

The desired clinical and economic outcomes can be positively affected by detecting abnormalities where they are first and best diagnosed and treated … in tissue microstructure.  Early diagnosis and treatment improves patient survival and cure rates and helps to avoid the costs, complications, and risks associated with dealing with advanced or recurring disease.  The favorable economics of improved care are clear.  Optimum clinical outcomes yield optimum economic outcomes.

Niris contributes to reducing healthcare costs through earlier detection of disease with fewer patient visits, and in the outpatient and ambulatory settings. The Niris Imaging System has the potential to significantly advance the practice of medicine and optimize the delivery of healthcare ... worldwide.  Imalux is literally putting advanced, real-time, site of care, “medical imaging in a new light.”

 

“OPTIMUM CLINICAL OUTCOMES YIELD OPTIMUM ECONOMIC OUTCOMES”